HA PHAN to Adult
This is a "connection" page, showing publications HA PHAN has written about Adult.
Connection Strength
0.046
-
Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial. J Infect. 2022 12; 85(6):625-633.
Score: 0.011
-
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy. Ann Clin Transl Neurol. 2022 06; 9(6):810-818.
Score: 0.010
-
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 2020 12; 8(12):1192-1200.
Score: 0.009
-
Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic. J Antimicrob Chemother. 2019 09 01; 74(9):2810-2821.
Score: 0.009
-
Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Clin Infect Dis. 2001 Feb 15; 32(4):534-8.
Score: 0.002
-
Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore). 2000 Jul; 79(4):210-21.
Score: 0.002
-
Genetic relatedness among nontypeable pneumococci implicated in sporadic cases of conjunctivitis. J Clin Microbiol. 1999 Dec; 37(12):4039-41.
Score: 0.002